Fyi here the response I received to the link regarding the trial.
"Just to confirm this press release is about the ongoing Phase 3 randomized controlled trial of remestemcel-L in patients with COVID-19 acute respiratory distress syndrome. This is being conducted in up to 30 hospitals, and now includes the Texas Heart Institute. Thank you for your support" Julie
- Forums
- ASX - By Stock
- MSB
- Cell Therapy News/Articles
Cell Therapy News/Articles, page-7713
-
- There are more pages in this discussion • 10,310 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add MSB (ASX) to my watchlist
|
|||||
Last
95.0¢ |
Change
-0.045(4.52%) |
Mkt cap ! $1.093B |
Open | High | Low | Value | Volume |
$1.00 | $1.01 | 94.5¢ | $2.464M | 2.554M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
4 | 17281 | 99.5¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
83.0¢ | 2748 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
4 | 17281 | 0.995 |
2 | 4573 | 0.975 |
1 | 7115 | 0.970 |
2 | 3029 | 0.965 |
4 | 107220 | 0.955 |
Price($) | Vol. | No. |
---|---|---|
0.830 | 2748 | 1 |
0.870 | 3287 | 1 |
0.895 | 50019 | 7 |
0.900 | 10000 | 1 |
0.905 | 9775 | 3 |
Last trade - 15.59pm 20/08/2024 (20 minute delay) ? |
Featured News
MSB (ASX) Chart |